Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury

Experimental Neurology

Volumn 160, Issue 1, 1999, Pages 124-132

  George, Annette ^a   Schmidt, Christine ^a   Weishaupt, Andreas ^a   Toyka, Klaus V ^a   Sommer, Claudia ^a  

^a NONE

Author keywords

Enzyme linked immunoassay (ELISA); Membrane TNF; Sedimental fraction; Tissue homogenization; Tumor necrosis factor (TNF); Wallerian degeneration

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDONEURIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HYPERALGESIA; MONONEUROPATHY; NERVE COMPRESSION; NERVE DEGENERATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

EID: 0032728373     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7193     Document Type: Article

References (46)

1. Aggarwal B. B., Natarajan K. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7:1996;93-124.
2. Bennett G. J., Xie Y. K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
3. Chen L. E., Seaber A. V., Wong G. H., Urbaniak J. R. Tumor necrosis factor promotes motor functional recovery in crushed peripheral nerve. Neurochem. Int. 29:1996;197-203.
4. Clancy K. D., Lorenz K., Hahn E., Christiansen B., Hofmann C., Gamelli R. L. Down-regulation of tissue specific tumor necrosis factor-alpha in the liver and lung after burn injury and endotoxemia. J. Trauma. 42:1997;169-176.
5. Clatworthy A. L., Illich P. A., Castro G. A., Walters E. T. Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci. Lett. 184:1995;5-8.
6. Cunha F. Q., Poole S., Lorenzetti B. B., Ferreira S. H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 107:1992;660-664.
7. DeLeo J., Colburn R., Rickman A. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res. 759:1997;50-57.
8. Eugui E., DeLustro B., Rouhafza S., Wilhelm R., Allison A. Coordinate inhibition by some antioxidants of TNF, IL-1, and IL-6 production by human peripheral blood mononuclear cell. Ann. NY Acad. Sci. 1997;171-184.
9. Ferreira S. H. The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs. 46:1993;1-9.
10. Garcia-Monco J. C., Benach J. L. Mechanisms of injury in Lyme neuroborreliosis. Semin. Neurol. 17:1997;57-62.
11. George A., Schmidt C., Sommer C. Quantification of TNF protein in homogenized rat sciatic nerve by ELISA. Soc. Neurosci. Abs. 24:1998;1539.
12. Gionchetti P., Campieri M., Belluzzi A., Bertinelli E., Ferretti M., Brignola C., Poggioli G., Miglioli M., Barbara L. Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches. Dig. Dis. Sci. 39:1994;1525-1531.
13. Griffin J. W., Wesselingh S. L., Griffin D. E., Glass J. D., McArthur J. C. Price Q. W., Perry S. W. HIV, AIDS and the Brain. 1994;159-182 Raven Press, New York.
14. Hoener M., Hewitt E., Conner J., Costello J., Varon S. Nerve growth factor content in adult rat brain tissues is several-fold higher than generally reported and is largely associated with sedimentable fractions. Brain Res. 728:1996;47-56.
15. Hotchkiss R., Osborne D., Lappas G., Karl I. Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor, interleukin-1 alpha and beta in amouse model of endotoxin. Shock. 3:1995;337-342.
16. Khanolkar-Young S., Rayment N., Brickell P. M., Katz D. R., Vinayakumar S., Colston M. J., Lockwood D. N. Tumour necrosis factor-alpha synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin. Exp. Immunol. 99:1995;196-202.
17. La Fleur M., Underwood J. L., Rappolee D. A., Werb Z. Basement membrane and repair of injury to peripheral nerve: Defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J. Exp. Med. 184:1996;2311-2326.
18. MacMaster M., Newton R., Sudhansu K., Andrews G. Activation and distribution of inflammatory cells in the mouse uterus during the preimplantation period. J. Immunol. 148:1992;1699-1705.
19. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., Nagatsu T. TNF alpha increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165:1994;208-219.
20. Newman K. M., Jean-Claude J., Li H., Ramey W. G., Tilson M. D. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation. 90:1994;II224-227.
21. Paya C., Leibson P., Patick A., Rodriguez M. Inhibition of Theiler's virus-induced demyelination in vivo by TNF. Int. Immunol. 2:1990;909-913.
22. Probert L. K., Selmaj. TNF and related molecules: Trends in neuroscience and clinical applications. J. Neuroimmunol. 72:1997;113-117.
23. Redford E. J., Hall S. M., Smith K. J. Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain. 118:1995;869-878.
24. Reichert F., Levitzky R., Rotshenker S. Interleukin-6 in intact and injured mouse peripheral nerves. Eur. J. Neurosci. 8:1996;530-535.
25. Rotshenker S., Aamar S., Barak V. Interleukin-1 activity in lesioned peripheral nerve. J. Neuroimmunol. 39:1992;75-80.
26. Saada A., Reichert F., Rotshenker S. Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and schwann cells. J. Cell Biol. 133:1996;159-167.
27. Said G. M., Hontebeyrie-Joskowicz M. Nerve lesions induced by macrophage activation. Res. Immunol. 143:1992;589-599.
28. Saito K., Suyama K., Nishida K., Sei Y., Basile A. S. Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci. Lett. 206:1996;149-152.
29. Sharief M., McLean B., Thompson E. Elevated serum levels of TNF in Guillain-Barre-Syndrome. Ann. Neurol. 33:1993;591-596.
30. Sommer C., Galbraith J. A., Heckman H. M., Myers R. R. Pathology of experimental compression neuropathy producing hyperesthesia. J. Neuropathol. Exp. Neurol. 52:1993;223-233.
31. Sommer C., Lalonde A., Heckman H. M., Rodriguez M., Myers R. R. Quantitative neuropathology of a focal nerve injury causing hyperalgesia. J. Neuropathol. Exp. Neurol. 54:1995;635-643.
32. Sommer C., Myers R. R. Vascular changes in a model of painful neuropathy. Exp. Neurol. 141:1996;113-119.
33. Sommer C., Schmidt C., George A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp. Neurol. 151:1998;138-142.
34. Sommer C., Marziniak M., Myers R. R. The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constrictive injury of rat sciatic nerve. Pain. 74:1998;83-91.
35. Sommer C., Schmidt C., George A., Toyka K. A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy. Neurosci. Lett. 237:1997;45-48.
36. Stashenko P., Jandinski J. J., Fujiyoshi P., Rynar J., Socransky S. S. Tissue levels of bone resorptive cytokines in periodontal disease. J. Periodontol. 62:1991;504-509.
37. Stoll G., Jung S., Jander S., van der Meide P., Hartung H. P. Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J. Neuroimmunol. 45:1993;175-182.
38. Takematsu H., Ohta H., Tagami H. Absence of tumor necrosis factor-alpha in suction blister fluids and stratum corneum from patients with psoriasis. Arch. Dermatol. Res. 281:1989;398-400.
39. Tracey D. J., Walker J. S. Pain due to nerve damage: Are inflammatory mediators involved. Inflamm. Res. 44:1995;407-411.
40. von Bieberstein S., Spiro J., Lindquist R., Kreutzer D. Enhanced tumor cell expression of TNF receptors in head and neck squamous cell carcinoma. Am. J. Surgery. 170:1995;416-422.
41. Wagner R., Myers R. R. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport. 7:1996;2897-2901.
42. Wagner R., Myers R. R. Schwann cells produce tumor necrosis factor alpha: Expression in injured and non-injured nerves. Neuroscience. 73:1996;625-629.
43. Wells M. R., Racis S. P. Jr., Vaidya U. Changes in plasma cytokines associated with peripheral nerve injury. J. Neuroimmunol. 39:1992;261-268.
44. Willenborg D., Fordham S., Cowden W., Ramshaw I. Cytokines and murine autoimmune encephalomyelitis: Inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol. 41:1995;31-41.
45. Zettler C., McLeod Bridges D., Zhou X., Rush R. Detection of increased tissue concentrations of nerve growth factor with an improved extraction procedure. J. Neurosci. Res. 46:1996;581-594.
46. Zhu J., Bai X. F., Mix E., Link H. Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: Dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin. Clin. Immunol. Immunopathol. 84:1997;85-94.